Cibus, Inc.

  • Market Cap: Micro Cap
  • Industry: Computers - Software & Consulting
  • ISIN: US17166A1016
USD
1.61
0.27 (20.15%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

377.72 k

Shareholding (Mar 2025)

FII

0.57%

Held by 19 FIIs

DII

77.21%

Held by 24 DIIs

Promoter

0.01%

How big is Cibus, Inc.?

22-Jun-2025

As of Jun 18, Cibus, Inc. has a market capitalization of 72.71 million, with net sales of 4.75 million and a net profit of -305.13 million over the last four quarters. The company reported shareholder's funds of 92.16 million and total assets of 350.07 million as of Dec 24.

Market Cap: As of Jun 18, Cibus, Inc. has a market capitalization of 72.71 million, categorizing it as a Micro Cap company.<BR><BR>Recent Quarterly Performance: For the latest four quarters, Cibus, Inc. reported net sales of 4.75 million and a net profit of -305.13 million.<BR><BR>Balance Sheet Snapshot: As of Dec 24, the company reported shareholder's funds of 92.16 million and total assets of 350.07 million.

Read More

What does Cibus, Inc. do?

22-Jun-2025

Cibus, Inc. is a micro-cap food and agriculture company that specializes in healthier specialty food ingredients and crop traits. As of March 2025, it reported net sales of $1 million and a net loss of $49 million, with a market cap of $72.71 million.

Overview: <BR>Cibus, Inc. is a food and agriculture company focused on delivering healthier specialty food ingredients and agriculturally advantageous crop traits, operating within the Computers - Software & Consulting industry and classified as a micro-cap company.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 1 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -49 Million (Quarterly Results - Mar 2025) <BR>Market cap: USD 72.71 Million (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: 2.69 <BR>Return on Equity: -132.88% <BR>Price to Book: 1.03<BR><BR>Contact Details: <BR>Address: 2800 Mount Ridge Rd, ROSEVILLE MN: 55113-4461 <BR>Tel: ['1 651 6832807', '1 949 4918235'] <BR>Fax: 1 302 6365454 <BR>Website: http://www.calyxt.com/

Read More

Should I buy, sell or hold Cibus, Inc.?

22-Jun-2025

Who are in the management team of Cibus, Inc.?

22-Jun-2025

As of March 2022, the management team of Cibus, Inc. includes Dr. Yves Ribeill (Chairman), Mr. James Blome (CEO), and several independent directors: Mr. Philippe Dumont, Mr. Jonathan Fassberg, Ms. Anna Kozicz-Stankiewicz, and Ms. Kimberly Nelson. They oversee the company's strategic direction and operations.

As of March 2022, the management team of Cibus, Inc. includes the following individuals:<BR><BR>- Dr. Yves Ribeill, Chairman of the Board<BR>- Mr. James Blome, Chief Executive Officer and Director<BR>- Mr. Laurent Arthaud, Director<BR>- Mr. Philippe Dumont, Independent Director<BR>- Mr. Jonathan Fassberg, Independent Director<BR>- Ms. Anna Kozicz-Stankiewicz, Independent Director<BR>- Ms. Kimberly Nelson, Independent Director<BR><BR>This team is responsible for overseeing the company's strategic direction and operations.

Read More

Is Cibus, Inc. overvalued or undervalued?

20-Sep-2025

As of March 21, 2024, Cibus, Inc. is rated as risky due to significant financial deterioration, overvaluation indicated by a negative P/E ratio and poor returns compared to peers and the S&P 500, with a year-to-date decline of -51.44% and a five-year drop of -99.58%.

As of 21 March 2024, the valuation grade for Cibus, Inc. has moved from does not qualify to risky, indicating a significant deterioration in its financial standing. The company appears to be overvalued given its current metrics, particularly with a Price to Book Value of 0.81 and an EV to EBITDA ratio of -3.40, which suggests that the market may not be accurately reflecting its financial health. Additionally, the Return on Capital Employed (ROCE) stands at a troubling -30.49%, further underscoring the company's challenges.<BR><BR>In comparison to its peers, Cibus, Inc. has a negative P/E ratio of -0.7651, while MediaAlpha, Inc. has a P/E of 14.7844, and OneSpan, Inc. shows a more favorable P/E of 9.8867, highlighting the relative weakness of Cibus in the industry. The company's stock has underperformed significantly against the S&P 500, with a year-to-date return of -51.44% compared to the index's 12.22%, and a staggering decline of -99.58% over the past five years. This performance reinforces the notion that Cibus, Inc. is currently overvalued in the market.

Read More

Is Cibus, Inc. technically bullish or bearish?

20-Sep-2025

As of September 3, 2025, Cibus, Inc. is in a bearish trend, indicated by negative signals from moving averages and Bollinger Bands, and has underperformed the S&P 500 with a year-to-date return of -51.44% compared to the S&P's 12.22%.

As of 3 September 2025, the technical trend for Cibus, Inc. has changed from mildly bearish to bearish. The current stance is bearish, with key indicators supporting this view including bearish signals from the daily moving averages, weekly KST, and monthly Dow Theory. While the weekly MACD shows a mildly bullish signal, the overall trend remains negative due to the bearish signals from Bollinger Bands and the monthly KST. <BR><BR>In terms of performance, Cibus has significantly underperformed the S&P 500 across all observed periods, with a year-to-date return of -51.44% compared to the S&P's 12.22%, and a one-year return of -62.45% versus the S&P's 17.14%.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of -15.73% and Operating profit at -21.89% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -17.54
  • NET PROFIT(9M) At USD -73.56 MM has Grown at -399.44%
  • DEBT-EQUITY RATIO (HY) Highest at 298.72 %
2

Risky - Negative EBITDA

3

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Computers - Software & Consulting

stock-summary
Market cap

USD 71 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

2.56

stock-summary
Return on Equity

-127.93%

stock-summary
Price to Book

0.98

Revenue and Profits:
Net Sales:
1 Million
(Quarterly Results - Jun 2025)
Net Profit:
-27 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
25.78%
0%
25.78%
6 Months
-42.5%
0%
-42.5%
1 Year
-63.33%
0%
-63.33%
2 Years
-88.39%
0%
-88.39%
3 Years
825.82%
0%
825.82%
4 Years
-98.58%
0%
-98.58%
5 Years
-99.08%
0%
-99.08%

Cibus, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
-15.73%
EBIT Growth (5y)
-21.89%
EBIT to Interest (avg)
-17.54
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
2.69
Sales to Capital Employed (avg)
0.01
Tax Ratio
0.01%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
42.18%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.81
EV to EBIT
-3.11
EV to EBITDA
-3.40
EV to Capital Employed
0.95
EV to Sales
51.87
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-30.49%
ROE (Latest)
-132.88%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 13 Schemes (22.21%)

Foreign Institutions

Held by 19 Foreign Institutions (0.57%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 12.50% vs 300.00% in Jun 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Jun 2025 is 6.67% vs -39.02% in Jun 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Jun'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.90",
          "val2": "0.80",
          "chgp": "12.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-16.40",
          "val2": "-19.70",
          "chgp": "16.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.60",
          "val2": "8.70",
          "chgp": "-1.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.80",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-26.60",
          "val2": "-28.50",
          "chgp": "6.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-19,234.70%",
          "val2": "-25,634.80%",
          "chgp": "640.01%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 138.89% vs 800.00% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 16.26% vs -1,897.63% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.30",
          "val2": "1.80",
          "chgp": "138.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-70.10",
          "val2": "-64.80",
          "chgp": "-8.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "33.60",
          "val2": "18.40",
          "chgp": "82.61%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-190.70",
          "val2": "-248.30",
          "chgp": "23.20%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-282.70",
          "val2": "-337.60",
          "chgp": "16.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-18,058.20%",
          "val2": "-38,230.00%",
          "chgp": "2,017.18%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoYstock-summary
Jun'25
Jun'24
Change(%)
Net Sales
0.90
0.80
12.50%
Operating Profit (PBDIT) excl Other Income
-16.40
-19.70
16.75%
Interest
8.60
8.70
-1.15%
Exceptional Items
0.00
-0.80
100.00%
Consolidate Net Profit
-26.60
-28.50
6.67%
Operating Profit Margin (Excl OI)
-19,234.70%
-25,634.80%
640.01%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Jun 2025 is 12.50% vs 300.00% in Jun 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Jun 2025 is 6.67% vs -39.02% in Jun 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
4.30
1.80
138.89%
Operating Profit (PBDIT) excl Other Income
-70.10
-64.80
-8.18%
Interest
33.60
18.40
82.61%
Exceptional Items
-190.70
-248.30
23.20%
Consolidate Net Profit
-282.70
-337.60
16.26%
Operating Profit Margin (Excl OI)
-18,058.20%
-38,230.00%
2,017.18%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 138.89% vs 800.00% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 16.26% vs -1,897.63% in Dec 2023

stock-summaryCompany CV
About Cibus, Inc. stock-summary
stock-summary
Cibus, Inc.
Computers - Software & Consulting
Calyxt, Inc. is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics. The Company products include Consumer Centric and Farmer Centric products. Consumer Centric product, which includes high oleic soybean, high fiber wheat, high fiber wheat II, reduced gluten wheat, cold storable potato and reduced browning potato. Farmer Centric products, which includes drought tolerant soybean, improved soybean, herbicide tolerant wheat, herbicide tolerant canola, herbicide tolerant alfalfa and herbicide quality alfalfa.The Company has several products under development including high oleic soybeans, powdery mildew resistant wheat and cold storable potato.
Company Coordinates stock-summary
Company Details
2800 Mount Ridge Rd , ROSEVILLE MN : 55113-4461
stock-summary
Tel: 1 651 68328071 949 4918235
stock-summary
Registrar Details